Sort
25,944 grants matching “neurodegeneration”
Homeostatic Stabilization of Neural Function in Health and Disease
$1,145,783Graeme W Davis · University Of California, San Francisco · R35 · FY2024 · NS
THE GENETICS AND MULTI-OMICS SPECIMENS CORE (GMSC)
$1,145,279Carlos Cruchaga · Washington University · U19 · FY2023 · AG
Functional Validation of TDP-43 splicing repression for frontotemporal degeneration
$1,145,275Philip C Wong · Johns Hopkins University · UH3 · FY2021 · NS
Glial Control of Neuron Development and Function
$1,144,125Shai Shaham · Rockefeller University · R35 · FY2025 · NS
Raman Spectroscopic Studies of Amyloids
$1,144,103Jennifer Lee · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
PHOSPHATIDYLINOSITOL SIGNALING AND HUMAN DISEASE
$1,144,086Philip W Majerus · Washington University · R01 · FY2010 · HL
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
$1,142,463Timothy J. Collier · Michigan State University · P50 · FY2012 · NS
Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease
$1,141,642Ajay Gupta · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease
$1,139,354Ronald B Tjalkens · Colorado State University · R35 · FY2023 · ES
Tissue Injury and Inflammation in Multiple Sclerosis
$1,139,190Richard M Ransohoff · Cleveland Clinic Lerner Com-Cwru · P50 · FY2009 · NS
Expanding insights into FTD disease mechanisms
$1,138,538Leonard Petrucelli · Mayo Clinic Jacksonville · R35 · FY2025 · NS
Neuronal Immunity in HIV Dementia
$1,137,512Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2007 · NS
Molecular Genetics Of Scrapie Pathogenesis
$1,135,879Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$1,135,517Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2019 · AG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild
$1,135,517Jeffrey L Ives · Acumen Pharmaceuticals, Inc. · U01 · FY2019 · AG
Molecular interplay between Aβ, tau and mTOR: Mechanisms of neurodegeneration
$1,134,150Salvatore Oddo · Arizona State University-Tempe Campus · RF1 · FY2016 · AG
Molecular and Cellular Biology of HIV Encephalopathy
$1,133,807Francisco A Gonzalez-Scarano · University Of Pennsylvania · P01 · FY2006 · NS
SV2A PET imaging in Alzheimer's Disease
$1,133,380Barbara Brigitta Bendlin · University Of Wisconsin-Madison · R01 · FY2020 · AG
Tau clearance and synaptic and cognitive function rescue by activation of mitochondrial clearance in tauopathy model
$1,132,981Shi Du Yan · Columbia University Health Sciences · RF1 · FY2025 · AG
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,132,610Aaron D. Gitler · Stanford University · R35 · FY2020 · NS
Neuroimaging Predictors of Cognitive Decline and Impairment
$1,132,531Susan Resnick · National Institute On Aging · ZIA · FY2017 · AG
Infrastructure for Translational Neuroscience Center
$1,132,390Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Glial Control of Neuron Development and Function
$1,131,689Shai Shaham · Rockefeller University · R35 · FY2023 · NS
Glial control of neuron development and function
$1,131,689Shai Shaham · Rockefeller University · R35 · FY2022 · NS
Glial control of neuron development and function
$1,131,689Shai Shaham · Rockefeller University · R35 · FY2021 · NS